PT1192122E - Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem - Google Patents

Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem

Info

Publication number
PT1192122E
PT1192122E PT00940462T PT00940462T PT1192122E PT 1192122 E PT1192122 E PT 1192122E PT 00940462 T PT00940462 T PT 00940462T PT 00940462 T PT00940462 T PT 00940462T PT 1192122 E PT1192122 E PT 1192122E
Authority
PT
Portugal
Prior art keywords
contain
preparation
pharmaceutical compositions
benzene derivatives
derivatives process
Prior art date
Application number
PT00940462T
Other languages
English (en)
Inventor
Pierre Casellas
Raymond Paul
Robert Boigegrain
Bernard Bourrie
Martine Bourrie
Jean Marc Herbert
Pierre Lair
Dino Nisato
Jean Claude Vernieres
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PT1192122E publication Critical patent/PT1192122E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
PT00940462T 1999-06-11 2000-06-08 Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem PT1192122E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907396A FR2794742B1 (fr) 1999-06-11 1999-06-11 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
PT1192122E true PT1192122E (pt) 2004-03-31

Family

ID=9546664

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00940462T PT1192122E (pt) 1999-06-11 2000-06-08 Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem

Country Status (33)

Country Link
US (1) US6482986B1 (pt)
EP (1) EP1192122B1 (pt)
JP (1) JP4711579B2 (pt)
KR (1) KR100668581B1 (pt)
CN (1) CN1210250C (pt)
AR (1) AR033793A1 (pt)
AT (1) ATE252542T1 (pt)
AU (1) AU768420B2 (pt)
BR (1) BR0011738A (pt)
CA (1) CA2374631C (pt)
CO (1) CO5180554A1 (pt)
CZ (1) CZ299659B6 (pt)
DE (1) DE60006113T2 (pt)
DK (1) DK1192122T3 (pt)
ES (1) ES2208345T3 (pt)
FR (1) FR2794742B1 (pt)
HK (1) HK1042891B (pt)
HU (1) HU228683B1 (pt)
IL (1) IL146545A0 (pt)
MX (1) MXPA01012783A (pt)
NO (1) NO327778B1 (pt)
NZ (1) NZ515529A (pt)
PL (1) PL196491B1 (pt)
PT (1) PT1192122E (pt)
RS (1) RS49998B (pt)
RU (1) RU2248964C2 (pt)
SI (1) SI1192122T1 (pt)
SK (1) SK286390B6 (pt)
TW (1) TWI279398B (pt)
UA (1) UA71959C2 (pt)
UY (1) UY26199A1 (pt)
WO (1) WO2000076953A1 (pt)
ZA (1) ZA200109486B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP1634598A1 (en) * 2004-09-07 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
US8039122B2 (en) 2005-03-28 2011-10-18 Semiconductor Energy Laboratory Co., Ltd. Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device
FR2887454B1 (fr) * 2005-06-28 2009-06-05 Sanofi Aventis Sa Combinaisons antitumorales contenant des derives du taxane et des sigma ligands
GB0514501D0 (en) * 2005-07-14 2005-08-24 Cambridge Lab Ireland Ltd Pharmaceutical compounds
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
US7731377B2 (en) * 2006-03-21 2010-06-08 Semiconductor Energy Laboratory Co., Ltd. Backlight device and display device
CN101506163B (zh) * 2006-08-30 2012-05-02 株式会社半导体能源研究所 合成蒽衍生物的方法和蒽衍生物、发光元件、发光装置、电子装置
GR1005865B (el) * 2007-01-17 2008-04-07 Anavex Life Sciences Corp. Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση.
US7723722B2 (en) 2007-03-23 2010-05-25 Semiconductor Energy Laboratory Co., Ltd. Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
FR2915994B1 (fr) * 2007-05-11 2009-07-03 Galderma Res & Dev Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique.
US20080286445A1 (en) * 2007-05-17 2008-11-20 Semiconductor Energy Laboratory Co., Ltd. Composition, and method of fabricating light-emitting element
GB0810857D0 (en) * 2008-06-13 2008-07-23 Cambridge Lab Ireland Ltd Pharmaceutical compounds
CN102089282A (zh) * 2008-07-08 2011-06-08 株式会社半导体能源研究所 咔唑衍生物、发光元件用材料、发光元件以及发光装置
GB2462611A (en) * 2008-08-12 2010-02-17 Cambridge Lab Pharmaceutical composition comprising tetrabenazine
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
GB2463451A (en) * 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
GB2463452A (en) * 2008-09-08 2010-03-17 Cambridge Lab Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
GB2463283A (en) * 2008-09-08 2010-03-10 Cambridge Lab 3,11b-cis-dihydrotetrabenazine for use in treating asthma
EP2330097B1 (en) * 2008-09-19 2013-01-23 Semiconductor Energy Laboratory Co, Ltd. Carbazole derivative and method for producing the same
WO2010059711A1 (en) * 2008-11-18 2010-05-27 Wisconsin Alumni Research Foundation Sigma-1 receptor ligands and methods of use
GR1006794B (el) 2009-02-26 2010-06-04 Αλεξανδρος Βαμβακιδης Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση
KR102225715B1 (ko) * 2013-07-09 2021-03-09 토소가부시키가이샤 아다만틸기를 가진 환상 아진 화합물, 제조 방법, 및 상기 화합물을 구성 성분으로서 함유하는 유기 전계발광소자
KR20170101128A (ko) 2016-02-26 2017-09-05 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
MA45793A (fr) 2016-07-27 2021-03-24 Univ Case Western Reserve Composés et procédés de stimulation de la myélinisation
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
WO2019126702A1 (en) 2017-12-22 2019-06-27 Case Western Reserve University Compounds for promoting myelination
AU2022332910A1 (en) * 2021-08-23 2024-03-07 Concordia University, Inc. Synthesis and evaluation of novel (4-hydroxyphenyl) substituted carbocycles as potent and selective estrogen receptor beta agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
FR2641276B1 (fr) * 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
ZA909902B (en) * 1989-12-21 1991-10-30 Himont Inc Graft copolymers of polyolefins and a method of producing same
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
US5449639A (en) 1994-10-24 1995-09-12 Taiwan Semiconductor Manufacturing Company Ltd. Disposable metal anti-reflection coating process used together with metal dry/wet etch
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales

Also Published As

Publication number Publication date
ZA200109486B (en) 2002-11-18
FR2794742B1 (fr) 2005-06-03
AR033793A1 (es) 2004-01-07
NZ515529A (en) 2004-01-30
CA2374631C (en) 2010-10-19
WO2000076953A1 (fr) 2000-12-21
EP1192122A1 (fr) 2002-04-03
CN1355782A (zh) 2002-06-26
ATE252542T1 (de) 2003-11-15
US6482986B1 (en) 2002-11-19
CZ299659B6 (cs) 2008-10-08
DK1192122T3 (da) 2004-03-01
CA2374631A1 (en) 2000-12-21
HK1042891B (zh) 2004-04-08
HU228683B1 (en) 2013-05-28
JP4711579B2 (ja) 2011-06-29
RU2248964C2 (ru) 2005-03-27
HK1042891A1 (en) 2002-08-30
SK286390B6 (sk) 2008-09-05
UA71959C2 (en) 2005-01-17
AU5539600A (en) 2001-01-02
NO327778B1 (no) 2009-09-21
PL196491B1 (pl) 2008-01-31
ES2208345T3 (es) 2004-06-16
RS49998B (sr) 2008-09-29
NO20016038D0 (no) 2001-12-10
YU87101A (sh) 2004-07-15
KR100668581B1 (ko) 2007-01-17
SI1192122T1 (en) 2004-04-30
FR2794742A1 (fr) 2000-12-15
CZ20014443A3 (cs) 2002-05-15
DE60006113D1 (de) 2003-11-27
PL352742A1 (en) 2003-09-08
AU768420B2 (en) 2003-12-11
BR0011738A (pt) 2002-03-05
CN1210250C (zh) 2005-07-13
CO5180554A1 (es) 2002-07-30
UY26199A1 (es) 2001-01-31
JP2003502306A (ja) 2003-01-21
HUP0201953A2 (hu) 2002-12-28
DE60006113T2 (de) 2004-07-15
IL146545A0 (en) 2002-07-25
SK18062001A3 (sk) 2002-05-09
KR20020009632A (ko) 2002-02-01
HUP0201953A3 (en) 2006-03-28
TWI279398B (en) 2007-04-21
NO20016038L (no) 2002-02-11
EP1192122B1 (fr) 2003-10-22
MXPA01012783A (es) 2002-09-18

Similar Documents

Publication Publication Date Title
PT1192122E (pt) Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem
PT1150961E (pt) Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1202965E (pt) Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao
BR0017030B1 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
PT1036794E (pt) Derivados de 2-aril-8-oxodi-hidropurina processo para a sua producao composicoes medicinais que os contem e seus intermediarios
PT1010423E (pt) Preparacao farmaceutica oral que contem um derivado benzimidazolico com accao anti-ulcerosa e processo para a sua producao
PT1339675E (pt) Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
BR9910900B1 (pt) compostos derivados de isotiazol, processo para sua preparação e composição farmacêutica dos mesmos
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
PT98369A (pt) Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem
PT885204E (pt) Novos derivados de arilglicinamida, processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos
PT99671A (pt) Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem
PT912613E (pt) Polissacaridos sinteticos processo para a sua preparacao e composicoes farmaceuticas que os contem
PT973763E (pt) Novos derivados do 2-(iminometil)amino-fenilo, sua preparacao, sua aplicacao na qualidade de medicamentos e composicoes farmaceuticas que os contem
PT97114A (pt) Processo para a preparacao de derivados de hidantoina e de composicoes farmaceuticas que os contem
PT101004A (pt) Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
PT1122254E (pt) Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT98365A (pt) Processo para a preparacao de novos derivados de oxalilo e de composicoes farmaceuticas que os contem
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
PT1049721E (pt) Polissacaridos de sintese processo para a sua preparacao e composicoes farmaceuticas que os contem
PT93067A (pt) Processo para a preparacao de derivados de 2-hidroxiacidos alifaticos e de eteres de 1-benzil-3-hidroximetilindazol, e de composicoes farmaceuticas que os contem
PT1118610E (pt) Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR1100524A (pt) Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
PT1165528E (pt) Novos derivados de morfolina, processo para a sua preparacao e composicoes farmaceuticas que os contem
PT1395582E (pt) Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem